Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

27:23

Editor's Note: As Shanghai hosts the 9th China International Import Expo (CIIE) from November 5 to 10, what opportunities will China's evolving market offer to multinational companies? As China enters a new phase of high-quality development, how are global companies positioning themselves for the opportunities ahead? On The Hub, Wang Guan speaks with Rogier Janssens, president of Merck China and managing director of Merck Life Science China. He looks at Merck's long-term investment strategy in China, its engagement with the country's innovation ecosystem, and the growing role of AI in biotechnology and cancer treatment.

Open in CGTN APP for better experience

Search Trends

China's high-quality development: A Merck China perspective